Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:14PM ET
1.58
Dollar change
-0.02
Percentage change
-1.25
%
Index- P/E- EPS (ttm)-0.22 Insider Own5.88% Shs Outstand26.35M Perf Week-1.25%
Market Cap41.63M Forward P/E- EPS next Y-0.19 Insider Trans0.00% Shs Float24.80M Perf Month-10.23%
Income-5.54M PEG- EPS next Q-0.06 Inst Own25.92% Short Float1.67% Perf Quarter-15.96%
Sales20.46M P/S2.03 EPS this Y13.58% Inst Trans-4.85% Short Ratio2.03 Perf Half Y-27.52%
Book/sh1.27 P/B1.25 EPS next Y18.57% ROA-15.26% Short Interest0.41M Perf Year31.67%
Cash/sh0.82 P/C1.92 EPS next 5Y15.00% ROE-20.81% 52W Range1.05 - 3.97 Perf YTD-10.73%
Dividend Est.- P/FCF- EPS past 5Y18.93% ROI-16.44% 52W High-60.20% Beta1.34
Dividend TTM- Quick Ratio4.29 Sales past 5Y-4.92% Gross Margin78.62% 52W Low50.48% ATR (14)0.14
Dividend Ex-Date- Current Ratio4.42 EPS Y/Y TTM59.25% Oper. Margin-38.05% RSI (14)47.16 Volatility5.02% 11.54%
Employees109 Debt/Eq0.01 Sales Y/Y TTM-26.79% Profit Margin-27.08% Recom1.00 Target Price4.83
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q142.20% Payout- Rel Volume0.22 Prev Close1.60
Sales Surprise10.73% EPS Surprise63.64% Sales Q/Q-26.94% EarningsMar 12 AMC Avg Volume203.83K Price1.58
SMA20-8.66% SMA501.07% SMA200-13.08% Trades Volume26,688 Change-1.25%
Date Action Analyst Rating Change Price Target Change
Jan-18-22Downgrade Guggenheim Buy → Neutral
Apr-22-21Initiated Guggenheim Buy $24
Mar-23-21Initiated BTIG Research Buy $25
Feb-26-21Initiated Oppenheimer Outperform $27
Jan-29-21Initiated Cantor Fitzgerald Overweight $19
Dec-03-20Initiated B. Riley Securities Buy $15
Feb-05-20Initiated JMP Securities Mkt Outperform $15
Jan-09-20Initiated Lake Street Buy $14
Dec-09-08Reiterated Canaccord Adams Buy $5 → $3.50
Aug-01-08Reiterated MDB Capital Group Buy $5.50 → $6
Mar-19-24 09:00AM
Mar-14-24 02:00PM
Mar-13-24 08:46AM
07:01AM
Mar-12-24 04:22PM
04:01PM Loading…
04:01PM
Mar-01-24 07:30AM
Feb-28-24 08:05AM
Feb-27-24 09:05AM
08:05AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Dec-18-23 08:00AM
Dec-05-23 06:00AM
Nov-28-23 08:00AM
08:00AM Loading…
Nov-27-23 08:00AM
Nov-22-23 08:12AM
Nov-20-23 08:00AM
Nov-14-23 10:56AM
08:00AM
Nov-13-23 04:06PM
04:01PM
Oct-30-23 08:00AM
Oct-24-23 04:03PM
Oct-23-23 08:01AM
Oct-08-23 07:19PM
Sep-01-23 05:07AM
Aug-27-23 11:53AM
Aug-16-23 08:00AM
Aug-15-23 07:58AM
05:48PM Loading…
Aug-14-23 05:48PM
04:01PM
08:00AM
Aug-07-23 11:49AM
Jul-31-23 08:00AM
Jul-25-23 09:34PM
Jul-23-23 09:49AM
Jul-18-23 08:00AM
Jul-12-23 08:00AM
Jul-10-23 08:00AM
Jul-07-23 02:30PM
Jun-25-23 02:17PM
Jun-08-23 06:31AM
May-18-23 04:40PM
08:00AM
May-16-23 11:13AM
May-15-23 05:25PM
04:22PM
04:01PM
May-11-23 08:00AM
May-03-23 08:00AM
May-01-23 08:00AM
Apr-25-23 08:00AM
Apr-20-23 08:00AM
Apr-17-23 08:00AM
Apr-07-23 04:28PM
Apr-06-23 06:08AM
Apr-05-23 06:11AM
Apr-04-23 08:00AM
Mar-30-23 08:26AM
Mar-28-23 05:15PM
04:01PM
07:47AM
Mar-23-23 08:00AM
Mar-14-23 03:42PM
Mar-13-23 08:30AM
08:00AM
Mar-01-23 08:00AM
Feb-23-23 10:14AM
Feb-12-23 09:12AM
Feb-09-23 08:00AM
Jan-23-23 08:00AM
Jan-11-23 08:00AM
Dec-30-22 07:11AM
Dec-22-22 06:00AM
Dec-09-22 09:00AM
Dec-08-22 08:00AM
Nov-28-22 08:00AM
Nov-21-22 08:00AM
Nov-19-22 07:07AM
Nov-17-22 08:02AM
Nov-15-22 04:13PM
Nov-14-22 08:00AM
Nov-10-22 05:45PM
04:03PM
04:01PM
Oct-27-22 08:40AM
Oct-19-22 07:02AM
Oct-14-22 11:34AM
Oct-11-22 08:00AM
Sep-07-22 08:00AM
Sep-05-22 07:34AM
Aug-29-22 08:00AM
Aug-19-22 09:35AM
Aug-11-22 07:00AM
Aug-10-22 05:55PM
04:30PM
04:07PM
Jul-27-22 08:00AM
06:21AM
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Dana RSee RemarksMar 31 '23Buy1.3040,00052,00040,000Apr 04 04:30 PM